Ascendis Pharma A (ASND) Operating Margin (QoQ) (2014 - 2026)

Ascendis Pharma A (ASND) Operating Margin (QoQ) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Ascendis Pharma A 15.31 Bn 14.64 Bn 268.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 769.00
Dec 31, 2025 -277.00
Sep 30, 2025 3,865.00
Jun 30, 2025 6,972.00
Mar 31, 2025 -12.37 Mn
Dec 31, 2024 12.37 Mn
Sep 30, 2024 20,290.00
Jun 30, 2024 -31,893.00
Mar 31, 2024 -3,916.00
Dec 31, 2023 26,772.00
Sep 30, 2023 1,735.00
Jun 30, 2023 13,060.00
Mar 31, 2023 21,598.00
Dec 31, 2022 30,134.00
Sep 30, 2022 135,836.00
Jun 30, 2022 -42,840.00
Mar 31, 2022 -174,435.00
Dec 31, 2021 857,836.00
Sep 30, 2021 280,061.00
Jun 30, 2021 519,943.00